Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma

Fig. 6

Clinical and immune analysis related to risk subgroups. A Differences in clinical data, DRGs, TMB, TIDE scores, and ssGSEA results between high and low-risk groups. TIDE scores and TMB are presented in the form of a bar chart and density plot respectively. B The differences in the abundance of immune cell infiltration algorithms in TIMER2.0 database including TIMER, CIBERSORT, CIBERSORT-ABS, MCPCOUNTER, XCELL, and EPIC between the high-risk and low-risk groups (the heatmap shows the results with statistical differences)

Back to article page